Antibody-mediated delivery of therapeutics has been primarily limited to agents containing amine, alcohol or thiol functional groups. Now, an approach has been developed to create stable and bio-reversible prodrugs that mask ortho-quinones. Drug release requires both protease activation followed by acid-assisted elimination.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Drago, J. Z., Modi, S. & Chandarlapaty, S. Nat. Rev. Clin. Oncol. 18, 327–344 (2021).
Staben, L. R. et al. Nat. Chem. 8, 1112–1119 (2016).
Kolakowski, R. V. et al. Angew. Chem. Int. Ed. 55, 7948–7951 (2016).
Dunsmore, L. et al. Nat. Chem. https://doi.org/10.1038/s41557-022-00964-7 (2022).
Chuprakov, S. et al. Bioconjug. Chem. 32, 746–754 (2021).
Gong, Q., Hu, J., Wang, P., Li, X. & Zhang, X. Eur. J. Med. Chem. 210, 112962 (2020).
Ma, X. et al. J. Control. Release 200, 201–211 (2015).
Lehar, S. M. et al. Nature 527, 323–328 (2015).
Gadd, A. J. R., Greco, F., Cobb, A. J. A. & Edwards, A. D. Bioconjug. Chem. 26, 1743–1752 (2015).
The author declares no competing interests.
About this article
Cite this article
Pillow, T. ortho-Quinone drugs go pro. Nat. Chem. 14, 719–720 (2022). https://doi.org/10.1038/s41557-022-00993-2